Alimera Sciences Inc., of Atlanta, reported a positive outcome of the repeat-use procedure for Iluvien for the treatment of chronic diabetic macular edema (DME) in an additional 10 European Union countries – Ireland, the Netherlands, Belgium, Luxembourg, Sweden, Denmark, Finland, Norway, Poland and the Czech Republic.